Development Level

Tbio 5 | 10,625
Tchem 4 | 1,890
Tclin 2 | 602

Disease

ovarian cancer 8 | 8,491
Cancer 7 | 2,346
glioblastoma 7 | 5,572
Breast cancer 6 | 3,098
cystic fibrosis 6 | 1,670
lung adenocarcinoma 6 | 2,714
lung cancer 6 | 4,473
psoriasis 6 | 6,685
diabetes mellitus 5 | 1,663
malignant mesothelioma 5 | 3,163
osteosarcoma 5 | 7,933
Atherosclerosis 4 | 275
Carcinoma 4 | 2,147
Kidney disease 4 | 397
Pancreatic Neoplasm 4 | 79
Prostatic Neoplasms 4 | 471
interstitial cystitis 4 | 2,299
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
medulloblastoma, large-cell 4 | 6,234
non-small cell lung cancer 4 | 2,798
pediatric high grade glioma 4 | 2,712
primitive neuroectodermal tumor 4 | 3,031
tuberculosis 4 | 1,563
ulcerative colitis 4 | 2,087
Acute kidney injury 3 | 65
Alzheimer's disease 3 | 644
Anemia 3 | 252
Cerebrovascular disease 3 | 231
Coronary artery disease 3 | 240
Diabetic Nephropathy 3 | 37
Diabetic Retinopathy 3 | 53
Heart disease 3 | 279
Hepatitis C 3 | 90
Hypersensitivity reaction type II disease 3 | 235
Hypertension 3 | 293
IGA Glomerulonephritis 3 | 454
Liver disease 3 | 219
Lung disease 3 | 136
Malaria 3 | 140
Mammary Neoplasms 3 | 410
Obesity 3 | 616
Peripheral vascular disease 3 | 90
atypical teratoid / rhabdoid tumor 3 | 4,369
ductal carcinoma in situ 3 | 1,745
invasive ductal carcinoma 3 | 2,950
nasopharyngeal carcinoma 3 | 1,056
ovarian neoplasm 3 | 97
pancreatic cancer 3 | 2,300
pilocytic astrocytoma 3 | 3,086
posterior fossa group A ependymoma 3 | 1,511
sarcoidosis 3 | 368
subependymal giant cell astrocytoma 3 | 2,287
Adenocarcinoma 2 | 115
Adenoid Cystic Carcinoma 2 | 99
Adenoma 2 | 165
Allergic hypersensitivity disease 2 | 123
Arthritis 2 | 248
Breast Cancer, Familial 2 | 12
Colorectal Neoplasms 2 | 217
Dementia 2 | 129
Diabetes Mellitus, Non-Insulin-Dependent 2 | 161
Diarrhea 2 | 155
Duodenal ulcer 2 | 20
Endometriosis 2 | 535
Hyperglycemia 2 | 120
Hypertensive disease 2 | 193
Hypoglycemia 2 | 81
Liver Cirrhosis, Experimental 2 | 108
Lobular neoplasia 2 | 15
Lung Neoplasms 2 | 171
Lynch syndrome 2 | 35
Malignant neoplasm of breast 2 | 63
Malignant neoplasm of ovary 2 | 13
Multiple Sclerosis 2 | 498
Myopathy 2 | 128
Neoplastic Cell Transformation 2 | 81
Neoplastic Syndromes, Hereditary 2 | 48
Neuropathy 2 | 210
Osteoporosis 2 | 259
Pancreatic carcinoma, familial 2 | 8
Pancreatitis 2 | 97
Peripheral Neuropathy 2 | 303
Prader-Willi syndrome 2 | 45
Prostate cancer 2 | 172
Proteinuria 2 | 63
Schizophrenia 2 | 503
Type 1 diabetes mellitus 2 | 104
astrocytic glioma 2 | 2,241
colon cancer 2 | 1,475
cutaneous lupus erythematosus 2 | 1,056
ependymoma 2 | 2,514
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
hepatocellular carcinoma 2 | 550
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
medulloblastoma 2 | 1,524
non-small cell lung carcinoma 2 | 413
pituitary cancer 2 | 1,972
sonic hedgehog group medulloblastoma 2 | 1,482
urothelial carcinoma 2 | 318

Tissue

Blood and immune system 11 | 17,994
Cardiovascular System 11 | 17,957
Digestive Tract 11 | 18,472
Endocrine System 11 | 18,511
Female tissues 11 | 18,646
Liver and Pancreas 11 | 18,135
Male tissues 11 | 17,968
Nervous System 11 | 18,560
Skin and soft tissues 11 | 18,114
Urinary Tract 11 | 18,443
Respiratory system 10 | 17,483

Target Family

Non-IDG 9 | 11,969
GPCR 1 | 408
Kinase 1 | 634

Grant Application

5P50CA083636-12 11 | 11
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Breast cancer type 1 susceptibility protein BRCA1 Tchem Non-IDG -3.74239 5756.8 1322
TBC1 domain family member 24 TBC1D24 Tbio Non-IDG -2.22045 137.3 20
Insulin INS Tbio Non-IDG -5.16178 141255.4 1549
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.11585 140.7 401
Breast cancer type 2 susceptibility protein BRCA2 Tbio Non-IDG -3.43517 2495.6 219
C-C chemokine receptor type 5 CCR5 Tclin GPCR -3.58221 4040.1 955
Vascular endothelial growth factor receptor 2 KDR Tclin Kinase -3.64428 4236.1 2079
Insulin-like growth factor-binding protein 2 IGFBP2 Tchem Non-IDG -2.91925 814.8 293
Mucin-16 MUC16 Tchem Non-IDG -2.05989 120.3 0
Transforming growth factor beta-1 TGFB1 Tchem Non-IDG -3.82684 20956.6 961